Central Bank & Trust’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-496
| Closed | -$3.38K | – | 236 |
|
|
2024
Q2 | $3.38K | Hold |
496
| – | – | ﹤0.01% | 344 |
|
|
2024
Q1 | $1.25K | Hold |
496
| – | – | ﹤0.01% | 328 |
|
|
2023
Q4 | $1.19K | Hold |
496
| – | – | ﹤0.01% | 343 |
|
|
2023
Q3 | $1.69K | Sell |
496
-125
| -20% | -$425 | ﹤0.01% | 323 |
|
|
2023
Q2 | $4.56K | Hold |
621
| – | – | ﹤0.01% | 303 |
|
|
2023
Q1 | $6.43K | Hold |
621
| – | – | ﹤0.01% | 298 |
|
|
2022
Q4 | $7.33K | Hold |
621
| – | – | ﹤0.01% | 298 |
|
|
2022
Q3 | $13K | Hold |
621
| – | – | ﹤0.01% | 266 |
|
|
2022
Q2 | $19K | Sell |
621
-14
| -2% | -$428 | ﹤0.01% | 260 |
|
|
2022
Q1 | $26K | Sell |
635
-392
| -38% | -$16.1K | ﹤0.01% | 251 |
|
|
2021
Q4 | $45K | Sell |
1,027
-258
| -20% | -$11.3K | 0.01% | 235 |
|
|
2021
Q3 | $64K | Sell |
1,285
-12,095
| -90% | -$602K | 0.01% | 211 |
|
|
2021
Q2 | $843K | Sell |
13,380
-36,809
| -73% | -$2.32M | 0.14% | 97 |
|
|
2021
Q1 | $4.66M | Buy |
50,189
+2,302
| +5% | +$214K | 0.8% | 46 |
|
|
2020
Q4 | $4.29M | Sell |
47,887
-108
| -0.2% | -$9.68K | 0.74% | 44 |
|
|
2020
Q3 | $4.96M | Buy |
47,995
+1,965
| +4% | +$203K | 0.93% | 39 |
|
|
2020
Q2 | $3.64M | Buy |
+46,030
| New | +$3.64M | 0.72% | 45 |
|